Robuta

https://atricure.compliancelinemcr.com/ AtriCure Portal atricureportal https://www.atricure.com/ AtriCure | Atrial Fibrillation Treatment | Pain Management AtriCure provides innovative atrial fibrillation (Afib) treatment solutions, including the AtriClip device for LAAM and other surgical ablation therapies. atrial fibrillation treatmentatricurepainmanagement https://theorg.com/org/atricure/teams/quality-assurance-and-compliance AtriCure - Quality Assurance and Compliance | The Org The Quality Assurance and Compliance team at AtriCure ensures that all products and processes meet regulatory standards and quality benchmarks. quality assuranceand complianceatricure https://www.macrotrends.net/stocks/charts/ATRC/atricure/gross-profit AtriCure Gross Profit 2012-2026 | ATRC | MacroTrends AtriCure gross profit from 2012 to 2026. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with... gross profitatricure20122026atrc https://www.businesswire.com/news/home/20260112726620/en/AtriCure-Reports-Preliminary-Results-for-Fourth-Quarter-and-Full-Year-2025-Provides-Financial-Outlook-for-2026 AtriCure Reports Preliminary Results for Fourth Quarter and Full Year 2025, Provides Financial... AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) managemen... https://www.finanzen.net/aktien/aktien_vergleich.asp?pkAktieNr=17650 ATRICURE AKTIE Vergleich | Peer Group | Wettbewerber | A0ES9W ATRICURE Aktienvergleich - vergleichen Sie hier die ATRICURE Aktie mit den entsprechenden Daten der Wettbewerber (Peer Group). Auch ein Chartvergleich der... peer groupatricureaktievergleichwettbewerber https://www.nasdaq.com/market-activity/stocks/atrc AtriCure, Inc. Common Stock (ATRC) Stock Price, Quote, News & History | Nasdaq Discover real-time AtriCure, Inc. Common Stock (ATRC) stock prices, quotes, historical data, news, and Insights for informed trading and investment decisions.... common stockprice quotenews historyatricureinc https://www.biospace.com/atricure-to-announce-third-quarter-2019-financial-results AtriCure to Announce Third Quarter 2019 Financial Results - BioSpace Oct 8, 2019 - AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced... 2019 financial resultsto announcethird quarteratricure https://theorg.com/org/atricure/teams/research-and-development AtriCure - Research and Development | The Org The Research and Development team at AtriCure focuses on advancing innovative technologies and solutions for atrial fibrillation through rigorous clinical... research and developmentatricure https://www.biospace.com/atricure-inc-to-announce-third-quarter-2009-financial-results AtriCure, Inc. to Announce Third Quarter 2009 Financial Results - BioSpace to announcethird quarterfinancial resultsatricureinc https://www.biospace.com/atricure-reports-preliminary-results-for-fourth-quarter-and-full-year-2020 AtriCure Reports Preliminary Results for Fourth Quarter and Full Year 2020 - BioSpace Jan 11, 2021 - AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, announced... preliminary resultsfourth quarter https://www.businesswire.com/news/home/20220607005182/en/AtriCure-Announces-the-First-Patient-Treated-in-the-HEAL-IST-Clinical-Trial AtriCure Announces the First Patient Treated in the HEAL-IST Clinical Trial AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) managemen... the firstatricureannouncespatient https://www.fool.com/investing/2018/10/05/why-chefs-warehouse-smart-global-holdings-and-atri.aspx Why Chefs' Warehouse, SMART Global Holdings, and AtriCure Jumped Today | The Motley Fool Oct 5, 2018 - Find out which of these companies did a great job raising money. https://www.businesswire.com/news/home/20210804005943/en/AtriCure-Reports-Second-Quarter-2021-Financial-Results?feedref=JjAwJuNHiystnCoBq_hl-ZuHAZxVRaQvQ0qaekuSK9f3_P53wLuJwyFVA4-mOrLx7fxFuNFTHSunhvli30RlBNXya2izy9YOgHlBiZQk2LP6oD-t3eB0qV-nJQ-WeFyCN1Simk7pbS0xXPOT069Puw%3D%3D AtriCure Reports Second Quarter 2021 Financial Results AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced s... second quarter2021 financialatricurereportsresults https://theorg.com/org/atricure/teams/sales-and-marketing AtriCure - Sales and Marketing | The Org The Sales and Marketing team at AtriCure is responsible for driving the adoption of innovative atrial fibrillation solutions through strategic marketing... sales and marketingatricure https://www.businesswire.com/news/home/20260414459021/en/AtriCure-to-Announce-First-Quarter-2026-Financial-Results AtriCure to Announce First Quarter 2026 Financial Results AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) managemen... first quarter 2026to announceatricurefinancialresults https://www.biospace.com/atricure-to-announce-third-quarter-2017-financial-results AtriCure To Announce Third Quarter 2017 Financial Results - BioSpace to announcethird quarterfinancial resultsatricure2017 https://www.biospace.com/atricure-inc-announces-web-cast-and-conference-call-of-second-quarter-2007-financial-results AtriCure, Inc. Announces Web Cast and Conference Call of Second Quarter 2007 Financial Results -... https://www.businesswire.com/news/home/20240515941063/en/AtriCure-to-Participate-in-the-2024-Leerink-Partners-Healthcare-Crossroads-Conference AtriCure to Participate in the 2024 Leerink Partners Healthcare Crossroads Conference AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) managemen... to participatein theleerink partnersatricure https://atricure.com/ AtriCure | Atrial Fibrillation Treatment | Pain Management AtriCure provides innovative atrial fibrillation (Afib) treatment solutions, including the AtriClip device for LAAM and other surgical ablation therapies. atrial fibrillation treatmentatricurepainmanagement https://www.businesswire.com/news/home/20240215724879/en/AtriCure-Reports-Fourth-Quarter-2023-and-Full-Year-2023-Financial-Results AtriCure Reports Fourth Quarter 2023 and Full Year 2023 Financial Results AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) managemen... fourth quarter2023 andfull yearatricurereports https://www.researchandmarkets.com/reports/5637104/atricure-inc-atrc-product-pipeline-analysis AtriCure Inc (ATRC) - Product Pipeline Analysis, 2025 Update AtriCure Inc (AtriCure) is a company specialising in the development and provision of medical technologies for the treatment of atrial fibrillation (Afib)... product pipelineanalysis 2025atricureincatrc https://www.concur.com/resource-center/casestudy/atricure-inc AtriCure Inc. | SAP Concur US As a customer of SAP Concur for more than a decade, AtriCure has continuously improved its Travel, Expense, and Invoice processes. As a medical device company,... sap concuratricureincus https://simplywall.st/stocks/us/healthcare/nasdaq-atrc/atricure/news/numerous-atricure-insiders-sold-stock-not-a-positive-omen Numerous AtriCure Insiders Sold Stock: Not A Positive Omen - Simply Wall St News A number of AtriCure, Inc. ( NASDAQ:ATRC ) insiders sold their shares in the last year, which may have raised concerns... https://stockhouse.com/companies/bullboard?symbol=atrc NDAQ:ATRC | Stock Discussion | AtriCure Inc Get stock insights, analysis and discussion about AtriCure Inc (NDAQ:ATRC). Join the ATRC discussion on Canada's largest online investor community ndaqatrcstockdiscussionatricure https://europe.atricure.com/ AtriCure | Europe & Middle East AtriCure provides innovative atrial fibrillation (Afib) treatment solutions, including the AtriClip device for LAAM and other surgical ablation therapies. atricureeuropemiddleeast https://www.biospace.com/atricure-to-announce-first-quarter-2023-financial-results AtriCure to Announce First Quarter 2023 Financial Results - BioSpace Apr 11, 2023 - AtriCure, Inc. today announced that it will release first quarter 2023 financial results on Tuesday, May 2, 2023. to announcefirst quarter2023 financialatricureresults https://www.uc.edu/news/articles/2024/04/atricure-top-co-op-employer-uc-biomedical-engineer-students.html AtriCure top co-op employer UC biomedical engineer students - University of Cincinnati: Founder of... Jan 13, 2025 - As one of the largest co-op employers in the region and a leading provider of innovative technologies for the treatment of Atrial Fibrillation and other... https://www.businesswire.com/news/home/20230419005096/en/AtriCure-to-Participate-in-the-2023-Bank-of-America-Health-Care-Conference-and-Host-a-Cryo-Nerve-Block-Therapy-Investor-Education-Webcast AtriCure to Participate in the 2023 Bank of America Health Care Conference and Host a Cryo Nerve... AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) managemen...